Chiron Behring Vaccines Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 12-07-2024
- Paid Up Capital ₹ 10.00 Cr
as on 12-07-2024
- Company Age 27 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.42 M
as on 12-07-2024
- Satisfied Charges ₹ 2.46 Cr
as on 12-07-2024
- Revenue 445.02%
(FY 2022)
- Profit 392.43%
(FY 2022)
- Ebitda 238.38%
(FY 2022)
- Net Worth 221.37%
(FY 2022)
- Total Assets 173.42%
(FY 2022)
About Chiron Behring Vaccines
The Corporate was formerly known as Chiron Behring Vaccines Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 10.00 Cr.
The company currently has active open charges totaling ₹0.42 M. The company has closed loans amounting to ₹2.46 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Chiron Behring Vaccines Private Limited India are Yedlapati Darsini as COMPANY SECRETARY and Srinivas Tadepally as Cfo. Sai Devarajulu and Raches Ella serve as directors at the Company.
- CIN/LLPIN
U24230PN1997PTC222142
- Company No.
111122
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Oct 1997
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Chiron Behring Vaccines Private Limited offer?
Chiron Behring Vaccines Private Limited offers a wide range of products and services, including Hosting Services, Dedicated Hosting Service, Anticoagulant and Antiplatelet Drugs, Enoxaparin Injection.
Who are the key members and board of directors at Chiron Behring Vaccines?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yedlapati Darsini  | Company Secretary | 26-Aug-2022 | Current |
| Srinivas Tadepally | CFO | 25-Jan-2020 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sai Devarajulu  | Whole-Time Director | 01-Mar-2019 | Current |
| Raches Ella | Director | 31-Aug-2019 | Current |
Financial Performance and Corporate Structure Insights of Chiron Behring Vaccines.
Chiron Behring Vaccines Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 445.02% increase. The company also saw a substantial improvement in profitability, with a 392.43% increase in profit. The company's net worth Soared by an impressive increase of 221.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chiron Behring Vaccines?
In 2022, Chiron Behring Vaccines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bharat Biotech International LimitedActive 28 years 10 monthsSai Devarajulu, Yedlapati Darsini and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 11 Aug 2020 | ₹0.42 M | Open |
Others Creation Date: 11 Aug 2020 | ₹4.59 M | Satisfied |
Bank Of America Natis Trust & Saving Assoen Creation Date: 22 Feb 1999 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Chiron Behring Vaccines?
Chiron Behring Vaccines has a workforce of 176 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chiron Behring Vaccines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chiron Behring Vaccines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
